Dupont De Nemours Inc Stock Price, News & Analysis

DuPont, Corteva, and Chemours have reached a binding agreement to settle disputes related to Chemours' 2015 spin-off. This includes a cost-sharing arrangement for PFAS liabilities and an escrow account totaling $1 billion over eight years. DuPont and Corteva will split costs up to $2 billion, with Chemours contributing additional funds. The companies will also resolve PFOA litigation in Ohio for $83 million, with contributions from each firm. The agreement aims to provide security for shareholders against future environmental claims.

The United Soybean Board (USB) is launching a pilot program from January 19 to March 19, 2021, in collaboration with Soylent and DuPont Nutrition & Biosciences to promote the Sustainably Grown U.S. Soy mark. This mark signifies soy ingredients that adhere to sustainable agricultural practices, enhancing consumer trust in U.S. soy products. Notably, consumer surveys indicate that nearly 70% would prefer products marked as sustainably grown. Following the pilot, USB will expand the mark's availability to interested companies, aiming to boost demand for responsibly grown U.S. soy.

Bernhard Capital Partners has appointed Luther C. Kissam, IV as Partner. Kissam, former CEO of Albemarle Corporation (NYSE: ALB), brings extensive experience in the transitional energy sector. He played a crucial role in Albemarle's $6.2 billion acquisition of Rockwood Holdings and is recognized for his contributions to the lithium market, vital for clean energy. Additionally, Jeffrey Koonce and Jonathan de Lauréal have been promoted to Partner and Managing Director, respectively, acknowledging their impactful contributions since joining the firm.

DuPont announced a split-off exchange offer allowing stockholders to exchange shares of DuPont for shares of Nutrition & Biosciences (N&B) at a 7% discount. This is part of a Reverse Morris Trust transaction with International Flavors & Fragrances (IFF). Stockholders can choose to tender some, all, or none of their shares, expecting to receive approximately $107.53 of N&B stock for every $100 of DuPont stock. The exchange offer runs until January 29, 2021, and the shares of N&B will convert to IFF shares post-merger, with a pro rata distribution planned if the offer is undersubscribed.

DuPont (NYSE: DD) announced the Board's approval of a separation of its Nutrition & Biosciences business through an exchange offer. Shareholders can exchange DuPont common stock for shares in Nutrition & Biosciences, Inc. Following this, a Reverse Morris Trust transaction will merge Nutrition & Biosciences with International Flavors & Fragrances (IFF). The split-off aims to enhance shareholder choice and efficiently retire shares, with a target closing date of February 1, 2021, for the merger.

DuPont (NYSE: DD) announced its third-quarter 2020 financial results, reporting net sales of $5.1 billion, down 6% year-over-year. Key segments like Electronics & Imaging saw growth, with sales rising 7%, while Transportation & Industrial experienced a 14% decline. GAAP EPS was $(0.11), influenced by impairment charges and lower segment results. Operating cash flow was $1.3 billion, aided by improved working capital. The company emphasizes cost control and anticipates adjusted EPS for full-year 2020 to be between $3.17 and $3.21. The focus remains on strategic divestitures to bolster shareholder value.

On October 14, 2020, DuPont's board announced a fourth quarter dividend of $0.30 per share on its Common Stock, payable on December 15, 2020. Shareholders of record as of November 30, 2020 will receive this dividend. This move reflects DuPont's ongoing commitment to returning value to its shareholders while sustaining its operations in various sectors such as electronics, construction, and health. More information about the company and its innovations can be found on their official website.

DuPont (NYSE: DD) has recognized four distinguished technology leaders as Laureates for 2020: Sourav Sengupta, Richard Jackson, Charlotte Horsmans Poulsen, and Christophe Fremaux. This year's title change from Fellow to Laureate reflects DuPont's commitment to advancing Diversity, Equity, and Inclusion (DE&I). The honorees have made significant contributions in their respective fields, impacting DuPont's business success. Each Laureate has a proven track record of innovation and leadership, with numerous patents and publications underscoring their expertise.